The same molecule can be a prescription drug in one channel and a gray-market research chemical in another. The distinction matters.
One of the most misunderstood aspects of the peptide space is that a single compound can occupy completely different regulatory positions depending on how it's supplied. Semaglutide obtained through a licensed prescriber is a regulated pharmaceutical. The same sequence sold as a research chemical is an entirely different risk profile.
Clinical channels come with identity verification, dosing oversight, pharmacovigilance, and manufacturing standards. Research channels come with none of those — the 'for research use only' label is a legal boundary, not a quality guarantee.
This site maps compounds to their status precisely because the pathway, not just the molecule, determines the real-world risk.
Keep exploring